Page last updated: 2024-08-22

trimetazidine and Parkinson Disease

trimetazidine has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Harmat, M; Janszky, J; Juhász, A; Kovács, N; Pintér, D1
Harmat, M; Janszky, J; Juhász, A; Kovács, M; Kovács, N; Pintér, D1
Arslan, Ş; Baş, YC; Üreyen, ÇM1

Other Studies

3 other study(ies) available for trimetazidine and Parkinson Disease

ArticleYear
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson's Disease.
    Scientific reports, 2020, 06-22, Volume: 10, Issue:1

    Topics: Aged; Aged, 80 and over; Female; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Trimetazidine

2020
Trimetazidine and parkinsonism: A prospective study.
    Parkinsonism & related disorders, 2019, Volume: 62

    Topics: Aged; Antiparkinson Agents; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Prospective Studies; Tremor; Trimetazidine

2019
Primum non nocere.
    Anatolian journal of cardiology, 2015, Volume: 15, Issue:1

    Topics: Aged, 80 and over; Beneficence; Female; Humans; Muscle Rigidity; Parkinson Disease; Trimetazidine

2015